Rapid staining and imaging of subnuclear features to differentiate between malignant and benign breast tissues at a point-of-care setting.

Journal Article (Journal Article)

PURPOSE: Histopathology is the clinical standard for tissue diagnosis; however, it requires tissue processing, laboratory personnel and infrastructure, and a highly trained pathologist to diagnose the tissue. Optical microscopy can provide real-time diagnosis, which could be used to inform the management of breast cancer. The goal of this work is to obtain images of tissue morphology through fluorescence microscopy and vital fluorescent stains and to develop a strategy to segment and quantify breast tissue features in order to enable automated tissue diagnosis. METHODS: We combined acriflavine staining, fluorescence microscopy, and a technique called sparse component analysis to segment nuclei and nucleoli, which are collectively referred to as acriflavine positive features (APFs). A series of variables, which included the density, area fraction, diameter, and spacing of APFs, were quantified from images taken from clinical core needle breast biopsies and used to create a multivariate classification model. The model was developed using a training data set and validated using an independent testing data set. RESULTS: The top performing classification model included the density and area fraction of smaller APFs (those less than 7 µm in diameter, which likely correspond to stained nucleoli).When applied to the independent testing set composed of 25 biopsy panels, the model achieved a sensitivity of 82 %, a specificity of 79 %, and an overall accuracy of 80 %. CONCLUSIONS: These results indicate that our quantitative microscopy toolbox is a potentially viable approach for detecting the presence of malignancy in clinical core needle breast biopsies.

Full Text

Duke Authors

Cited Authors

  • Mueller, JL; Gallagher, JE; Chitalia, R; Krieger, M; Erkanli, A; Willett, RM; Geradts, J; Ramanujam, N

Published Date

  • July 2016

Published In

Volume / Issue

  • 142 / 7

Start / End Page

  • 1475 - 1486

PubMed ID

  • 27106032

Pubmed Central ID

  • PMC4900949

Electronic International Standard Serial Number (EISSN)

  • 1432-1335

Digital Object Identifier (DOI)

  • 10.1007/s00432-016-2165-9


  • eng

Conference Location

  • Germany